애완동물 암 치료제 시장 규모, 점유율, 성장 분석 : 종별, 치료법별, 투여 경로별, 암 유형별, 지역별 - 업계 예측(2026-2033년)

Pet Cancer Therapeutics Market size was valued at USD 441.4 Million in 2024 and is poised to grow from USD 484.66 Million in 2025 to USD 1023.89 Million by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The pet cancer therapeutics market is experiencing significant growth, reflecting an increasing focus on advancements in pet healthcare. As pet owners prioritize their companions' health, there is rising demand for effective cancer treatment options. This surge is fueled by a heightened awareness of pet health and an understanding that providing optimal care is crucial. Key market players are innovating with new therapies designed specifically for pets, enhancing their chances of survival and quality of life post-diagnosis. Additionally, developments in veterinary oncology are enabling a deeper understanding of pet cancers, leading to the creation of targeted treatment solutions. Overall, the market represents a dynamic intersection of compassion and scientific innovation, addressing the specialized healthcare needs of cherished pets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pet Cancer Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pet Cancer Therapeutics Market Segments Analysis

Global Pet Cancer Therapeutics Market is segmented by Species, Therapy, Route of Administration, Cancer Type and region. Based on Species, the market is segmented into Dogs, Cats and Other species. Based on Therapy, the market is segmented into Chemotherapy, Immunotherapy, Targeted therapy and Combination therapy. Based on Route of Administration, the market is segmented into Oral and Injection. Based on Cancer Type, the market is segmented into Lymphoma, Mast cell cancer, Melanoma, Mammary and squamous cell cancer and Other cancer types. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pet Cancer Therapeutics Market

A significant factor propelling the growth of the pet cancer therapeutics market is the growing trend of pet humanization. As pet owners increasingly regard their animals as cherished family members, their readiness to invest in sophisticated healthcare options, such as cancer treatments, has intensified. This shift in perception has led to a heightened demand for effective and compassionate cancer therapies designed specifically for pets. Consequently, this trend fosters innovation within the industry and stimulates market expansion, as companies strive to develop advanced solutions that cater to the evolving needs of pet owners committed to ensuring the health and well-being of their beloved companions.

Restraints in the Pet Cancer Therapeutics Market

A notable limitation within the pet cancer therapeutics market is the considerable financial burden presented by cancer treatments for pets. The high costs associated with various medical interventions, such as diagnostics, surgical procedures, radiation therapy, and medications, can deter pet owners from pursuing advanced care options for their beloved animals. This financial strain may force many to make challenging decisions regarding the level of treatment they can provide, ultimately hindering their access to potentially life-saving therapies. Consequently, despite a growing awareness and demand for these therapeutics, the issue of affordability significantly influences market dynamics and the availability of effective treatments for pets.

Market Trends of the Pet Cancer Therapeutics Market

The pet cancer therapeutics market is experiencing a pronounced trend toward personalized treatment strategies that cater to the unique needs of individual pets. Pet owners and veterinarians are increasingly acknowledging the variance in cancer types and treatment responses among different animals, which is prompting a heightened demand for customized therapeutic solutions. Innovations in diagnostics, including genetic profiling and molecular testing, are paving the way for accurate cancer diagnoses, allowing for the development of targeted therapies that align with the specific characteristics of each pet's cancer. This shift not only enhances treatment efficacy but also minimizes adverse effects, demonstrating a robust commitment to improving care quality and patient outcomes in veterinary oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis

Global Pet Cancer Therapeutics Market Size by Species & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Other species

Global Pet Cancer Therapeutics Market Size by Therapy & CAGR (2026-2033)

• Market Overview
• Chemotherapy
• Immunotherapy
• Targeted therapy
• Combination therapy

Global Pet Cancer Therapeutics Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injection

Global Pet Cancer Therapeutics Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Lymphoma
• Mast cell cancer
• Melanoma
• Mammary and squamous cell cancer
• Other cancer types

Global Pet Cancer Therapeutics Market Size & CAGR (2026-2033)

• North America (Species, Therapy, Route of Administration, Cancer Type)
  • US
  • Canada
• Europe (Species, Therapy, Route of Administration, Cancer Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Species, Therapy, Route of Administration, Cancer Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Species, Therapy, Route of Administration, Cancer Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Species, Therapy, Route of Administration, Cancer Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Elanco Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anivive Lifesciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneus (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qbiotics (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetDC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AB Science (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vet Cancer Group (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetriScience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetnostics (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veterinary Cancer Society (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetCure Oncology (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oasmia Pharmaceutical (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations